"Parkinson's disease and ALS represent two devastating
neurodegenerative diseases for which there are currently no truly
effective therapies., President and Chief Scientific Officer of Cambria
Biosciences. Robert McNally , President of
Cell Design LLC.

fatigue cord

----Cambria Biosciences
LLC, a drug discovery company, today announced that it has been
awarded three new Phase I Small Business Innovation Research (SBIR)
grants totaling more than $700,000 from the National Institutes of
Health to support the company's drug discovery program for
neurodegenerative diseases. Cambria investigators will use the SBIR funding to
develop new disease models that incorporate both genetic and
environmental features in order to devise more efficacious therapies
for this multifactorial neurodegenerative disorder.

ProCord Trial for Complete Spinal Cord Injury Now Live at Shepherd Center in Atlanta

demyelinating cord

com

This release contains certain forward-looking statements which
involve known and unknown risks, delays, uncertainties and other
factors not under the respective company's control which may cause
actual results, performance or achievements of that company to be
materially different from the results, performance or other
expectations implied by these forward-looking statements.

Shepherd Center in Atlanta is the country's largest catastrophic
care hospital specializing in the treatment of people with spinal cord
injury and disease, acquired brain injury, multiple sclerosis and
other neuromuscular disorders and urological problems.

headaches spinal

For more information, please visit
www. We appreciate his thoughtful consideration of this critical issue.

Shepherd Center has been enrolling patients in the
study as an IRB patient referral and follow up site for more than a
year. Its products are based on proprietary technology
licensed from Yeda for modulating the interaction between the nervous
and immune systems .
The Company is also developing PN277 for the treatment of additional
neurodegenerative diseases .

chronic spinal

5 million Americans
are currently afflicted by this progressive movement disorder, and
60,000 new cases are diagnosed each year. Several genetic mutations
have recently been discovered to cause rare familial forms of
Parkinson's disease, but environmental factors contribute to the vast
majority of cases.
Fax: 1-866-214-7078

Callers outside of the U., please use standard
international dialing code.spinalcordtrial.

parkinson peripheral

Cambria will seek to
elucidate the molecular sites of action of riluzole, the only drug
currently approved for the treatment of ALS, in order to provide
insights into designing better medicines for ALS."

About CRF
The Christopher Reeve Foundation (CRF) is committed to funding research
that develops treatments and cures for paralysis caused by spinal cord injury
and other central nervous system disorders.

neurological epilepsy

is a privately held
biopharmaceutical company developing products for the medical
treatment of spinal cord injuries and other disorders of the central
nervous system .

palsy jakob

D.shepherd. The latter is being managed by Teva as part of the
Proneuron's strategic collaboration for development and
commercialization of Cop-1 for various neurodegenerative indications.

disorders neurological

org.

diseases fatigue

WASHINGTON, "On behalf of the Christopher Reeve
Foundation and the millions of people living with paralysis, we applaud
Senator Frist for his support of the Stem Cell Research Enhancement Act. The Foundation also vigorously
works to improve the quality of life for people living with disabilities
through its grants program, paralysis resource center, and advocacy efforts., MD, Emeritus Medical Director of
Shepherd Center.
The Marcus Foundation provided the $3. Cell Dynamics LLC specializes in human tissues and is
currently focusing on the development of neonatal stem cells for
therapeutic applications.

neuralgias hydrocephalus

According to the National Parkinson Foundation, 1. Stem
cells have the potential to cure diseases and conditions ranging from spinal
cord injury, Parkinson's disease and multiple sclerosis, to diabetes and heart
disease. We are proud
of the role Christopher Reeve and the Foundation have played in advancing this
legislation and we look to Senator Frist's leadership to quickly pass the Stem
Cell Research Enhancement Act in the United States Senate this fall. David Snyder, V.

neurological cerebral

Pharmaceutical Writers/Business Editors/Health/Medical
Writers/Biotech Writers
BIOWIRE2K

WOBURN, Mass.
Dr.S.

spinal bifida

Cambria Biosciences Awarded Three Small Business Innovation Research Grants from National Institutes of Health for Company's Neurodegenerative Disease Program

The
Company is applying this platform to focus on new therapeutics for
neurodegenerative diseases and infectious disease pests.

chronic congenital

Amyotrophic lateral sclerosis (ALS), better known as Lou Gehrig's
disease , is the focus of Cambria's third SBIR grant, from the National
Institute of Neurological Disorders and Stroke. These
factors include results of current or pending research and development
activities , actions by regulatory authorities, and other activities.trial@proneuron.S.

For complete details about the study: www. Shepherd Center
is the largest Model Center for spinal cord injury in the country,
serves as one of the largest brain injury programs in Georgia, and is
an official Multiple Sclerosis Center, designated the National
Multiple Sclerosis Society--Georgia Chapter.

spina bifida

ALS is a degenerative
disease of motor neurons that results in progressive muscle weakness
leading to paralysis and death, thereby placing enormous emotional and
economic burdens on patients and their families.
"The ProCord trial continues and is currently live at Shepherd
Center.org

Proneuron Biotechnologies Inc.

spinal demyelinating

These NIH grants leverage Cambria's unique
ability to develop predictive biological models of these diseases and
to identify the molecular modes of action for promising compounds,"
said Leo Liu, M. It is important to remember that qualifying patients
must be enrolled within 12 days of their injury in order to receive
ProCord within the 14-day study protocol window. toll free) or 1-506-652-3486., Belgium and
Israel.

spina chronic

For more information, please call (800) 225-0292 or visit
http://www. We are now fully equipped to provide both the surgical and the
post-operative rehabilitation portions of this experimental treatment.

fatigue hydrocephalus

2 million in financing used
to build the ProCord processing cell center at Cell Design and to
begin the implementation of the study at Shepherd Center .

Cell Design LLC, a wholly owned subsidiary of Cell Dynamics LLC,
is a privately held human tissue facility located in Smyrna Georgia.
ProCord, an autologous cell therapy for patients with spinal cord
injuries, will be processed in a cGMP laboratory in accordance with
FDA guidelines .

parkinson spina

About Cambria Biosciences

Cambria Biosciences LLC is a Boston-area biopharmaceutical company
that combines the power of genetics and high-throughput chemical
screening to discover new drug candidates and how they work.
Senator Frist's announcement brings us one step closer to expanding federal
funding of embryonic stem cell research and harnessing the power of government
to find better treatments and cures for millions of Americans.

cord sclerosis

With the completion of the establishment and operation of a
specially designed cell processing center at Cell Design LLC in
Atlanta, Shepherd Center has the necessary tools to implement the
surgical segment of the experimental therapy. The company's products are currently being
evaluated in several clinical studies located in the U. These include: an independently managed, international,
multi-center, randomized-controlled Phase II trial of ProCord,
autologous incubated macrophages, an experimental procedure for spinal
cord injuries and a Phase II program of Cop-1 for the treatment of
Huntington's disease (HD), Glaucoma and other neurodegenerative
diseases.

epilepsy palsy

In addition,
Cambria earns revenues from corporate partnerships that leverage its
technology platform for multiple applications, including agriculture
and animal health .
"We are proud to be an active part of this worthy initiative and
are hopeful that this enormous effort will result in the improvement
of the well being of patients," said Dr.P. Founded in 1975 , the
100-bed not-for-profit hospital offers a continuum of health care
services, from intensive care through inpatient medical surgical care,
rehabilitation, day program, and outpatient and residential services.

creutzfeldt migraine

By
characterizing the biological mechanism of each promising compound
lead in living biological systems that serve as models for human
disease, these technologies provide a rapid way to enhance the
therapeutic potential of biologically active small molecules.

com.

muscular migraine

Parkinson 's disease is the focus of two of Cambria's SBIR grants,
one from the National Institute of Neurological Disorders and Stroke
and one from the National Institute of Environmental Health Sciences.ChristopherReeve .
We look forward to continuing our participation in this very important
research," said David Apple, Jr.S.

An organized network of people with something in common who give and receive help, advice , friendship and emotional support.

migraine diseases

Business Editors/Biotech Writers

ATLANTA----Shepherd Center announced
today that it is now a treatment site for Proneuron's Phase II,
multi-center , randomized-controlled trial of ProCord for complete
spinal cord injury.com
Telephone: 1 -866-539-0767 (U.

muscular jakob

cambriabio.

Statement from Michael Manganiello Senior Vice President of Government Relations Christopher Reeve Foundation

of Clinical Development at Proneuron
commented, "Timing is a crucial element in this study, from the
admission of patients through the implantation of the autologous
cellular product."

Patient, Immediate Family of Patient and/or Physician inquiries:
24 hour a day Patient Recruitment Center:
Email: clinical.
For more information, visit www.